,title,source,link,date
67,Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T ...,BMC Medicine,news.google.com/articles/CBMiSWh0dHBzOi8vYm1jbWVkaWNpbmUuYmlvbWVkY2VudHJhbC5jb20vYXJ0aWNsZXMvMTAuMTE4Ni9zMTI5MTYtMDIzLTAzMDE2LTDSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-28
39,QMines acquires copper-zinc project with â€œimmediate synergies and ...,Proactive Investors UK,news.google.com/articles/CBMivwFodHRwczovL3d3dy5wcm9hY3RpdmVpbnZlc3RvcnMuY28udWsvY29tcGFuaWVzL25ld3MvMTAyNDY3OS9xbWluZXMtYWNxdWlyZXMtY29wcGVyLXppbmMtcHJvamVjdC13aXRoLWltbWVkaWF0ZS1zeW5lcmdpZXMtYW5kLXNjYWxlLXNlY3VyZXMtMy1taWxsaW9uLWluLWZ1bGx5LXN1YnNjcmliZWQtcGxhY2VtZW50LTEwMjQ2NzkuaHRtbNIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-28
76,Sarytogan Graphite's 99.99% graphite purity 'shoots the lights out ...,Proactive Investors UK,news.google.com/articles/CBMilQFodHRwczovL3d3dy5wcm9hY3RpdmVpbnZlc3RvcnMuY28udWsvY29tcGFuaWVzL25ld3MvMTAyNDY3MS9zYXJ5dG9nYW4tZ3JhcGhpdGUtcy05OS05OS1ncmFwaGl0ZS1wdXJpdHktc2hvb3RzLXRoZS1saWdodHMtb3V0LXNoYXJlcy1zb2FyLTEwMjQ2NzEuaHRtbNIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-28
1,Niraparib Maintenance Extends PFS in Newly Diagnosed Ovarian ...,OncLive,news.google.com/articles/CBMiYGh0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvbmlyYXBhcmliLW1haW50ZW5hbmNlLWV4dGVuZHMtcGZzLWluLW5ld2x5LWRpYWdub3NlZC1vdmFyaWFuLWNhbmNlctIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-27
3,Atezolizumab Plus Cabozantinib Meets PFS End Point in Phase 3 ...,www.oncnursingnews.com/,news.google.com/articles/CBMilgFodHRwczovL3d3dy5vbmNudXJzaW5nbmV3cy5jb20vdmlldy9hdGV6b2xpenVtYWItcGx1cy1jYWJvemFudGluaWItbWVldHMtcGZzLWVuZC1wb2ludC1pbi1waGFzZS0zLWNvbnRhY3QtMDItdHJpYWwtaW4taG9ybW9uZS10aGVyYXB5LXByZXRyZWF0ZWQtbWNycGPSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-27
52,Zhen Explores the Role of Immunotherapy in Upper GI Cancers,Targeted Oncology,news.google.com/articles/CBMiXGh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L3poZW4tZXhwbG9yZXMtdGhlLXJvbGUtb2YtaW1tdW5vdGhlcmFweS1pbi11cHBlci1naS1jYW5jZXJz0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-27
70,Zimbabwes President Emmerson Mnangagwa re-elected for second ...,webindia123,news.google.com/articles/CBMiRmh0dHBzOi8vbmV3cy53ZWJpbmRpYTEyMy5jb20vbmV3cy9hcnRpY2xlcy9Xb3JsZC8yMDIzMDgyNy80MTEyNzE4Lmh0bWzSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-27
21,Up-to-date meta-analysis of long-term evaluations of mesenchymal ...,Newswise,news.google.com/articles/CBMikQFodHRwczovL3d3dy5uZXdzd2lzZS5jb20vYXJ0aWNsZXMvdXAtdG8tZGF0ZS1tZXRhLWFuYWx5c2lzLW9mLWxvbmctdGVybS1ldmFsdWF0aW9ucy1vZi1tZXNlbmNoeW1hbC1zdGVtLWNlbGwtdGhlcmFweS1mb3ItY29tcGxleC1wZXJpYW5hbC1maXN0dWxh0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
62,Ivonescimab Challenges Tislelizumab Plus Chemo in Advanced ...,Targeted Oncology,news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L2l2b25lc2NpbWFiLWNoYWxsZW5nZXMtdGlzbGVsaXp1bWFiLXBsdXMtY2hlbW8taW4tYWR2YW5jZWQtZWdmci1ucy1uc2NsY9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
40,Next Steps for Acalabrutinib in MCL,Targeted Oncology,news.google.com/articles/CBMiRGh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L25leHQtc3RlcHMtZm9yLWFjYWxhYnJ1dGluaWItaW4tbWNs0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
